Tuesday, 20 October 2015
Meeting category
Date(s)
20 Oct 2015
Location
Barcelona,
Spain
Organizer
HIV Clinical Forum 2015
Related Enduring Materials
Enduring Materials
-
Anna Maria Geretti, MD, PhD, FRCPath
Basic Science of Integrase Inhibitors
Resistance characteristics of Integrase Inhibitors
Pharmacological considerations
Integrating science into the clinic: current and future use of integrase Inhibitors
Skills improvement Session 1: Designing clinical trials: Highlights and tips
Skills improvement Session 2: Analyzing clinical datasets: Challenges and pitfalls
Clinical case presentations and discussion in small breakout sessions
University of Rome, Italy / King's College London, United Kingdom
Overview
Welcome
Dear colleague,
The 1st HIV Forum, held in Barcelona, Spain on 20 October 2015, was very successful. Participants from 22 countries had a great opportunity to share their experience and exchange ideas.
The first HIV Forum focused entirely on Integrase Inhibitors as Integrase Inhibitors are rapidly gaining a central role in the routine care of HIV infected individuals.
The HIV Forum meetings aim at enhancing the clinical skills and research capabilities of HIV healthcare professionals in regard to this unique class of antiretroviral drugs.
The program of the 1st HIV Forum Meeting consisted of state of the art lectures on basic science and optimal treatment management involving Integrase Inhibitors, abstract driven presentations and clinical case presentations.
Much time was reserved for Q&A and discussion. This lead to stimulating interactions and exchange of clinical experience with Integrase Inhibitors among the audience.
On behalf of the Forum Chairs we thank all participants making this first meeting a great success.
The Forum Chairs
Forum Chairs
General Information
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of HIV-positive individuals
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of HIV-positive individuals
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand the clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might best benefit from long acting injectable regimens
- Know how best to integrate injectable drugs in to routine clinical care
- Understand the clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might best benefit from long acting injectable regimens
- Know how best to integrate injectable drugs in to routine clinical care
Endorsers
